Community-reported Velcade side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Velcade Side Effect
Have You dealt with a Velcade side effect? Share your experience
Review Velcade Safety Reports submitted to FDA
Total Velcade reports: 2239.Velcade FDA safety alerts: No.
Reported deaths: 746 Reported hospitalizations: 1286.
Take Velcade Side Effects Survey, Discuss Velcade with others
FDA Reported Velcade Side Effects: diarrhoea, thrombocytopenia, pyrexia, disease progression, asthenia, neuropathy peripheral, platelet count decreased, hypotension, blood lactate dehydrogenase increased, atrial fibrillation, nausea.
Velcade Usage.
If you have questions about Velcade, you can ask a Health Expert or Ask Patient Community about Velcade.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
< Previous Showing 201-300 of 2239 Next >
Velcade Side Effects Report #5634199-6Physician from POLAND reported VELCADE problem on Feb 07, 2008. Male patient, 65 years of age, weighting 149.9 lb, was diagnosed with plasmacytoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5635701-0
VELCADE problem was reported by a Physician from PORTUGAL on Feb 06, 2008. Female patient, 85 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cardio-respiratory arrest, cerebrovascular accident, coma, hypoxic encephalopathy, myocardial ischaemia, spinal cord disorder, ventricular fibrillation. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, LANOXIN, TICLOPIDINE, DARBEPOETIN ALFA, PAMIDRONATE DI. Patient was hospitalized. Patient died on 02/03/2008.
Velcade Side Effects Report #5635709-5
Physician from GERMANY reported VELCADE problem on Feb 06, 2008. Male patient, child 6 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, cachexia, personality change. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5635710-1
VELCADE problem was reported by a Physician from EGYPT on Feb 07, 2008. Female patient, 58 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: dehydration, gastrointestinal disorder. VELCADE dosage: 1.30 MG/M2. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5635713-7
Physician from NETHERLANDS reported VELCADE problem on Feb 07, 2008. Male patient, 64 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, glomerulonephritis. VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5635715-0
VELCADE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 08, 2008. Male patient was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: post procedural haemorrhage, splenic haemorrhage. VELCADE dosage: 1.30 MG. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5635716-2
Physician from RUSSIAN FEDERATION reported VELCADE problem on Feb 07, 2008. Female patient, 65 years of age, weighting 178.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: angina unstable, cardiac failure chronic, pyelonephritis acute. VELCADE dosage: 2.50 MG. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient was hospitalized and became disabled. Patient recovered.
Velcade Side Effects Report #5635717-4
VELCADE problem was reported by a Physician from FRANCE on Feb 07, 2008. Male patient, 58 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, bronchopulmonary aspergillosis, cellulitis, pancreatitis haemorrhagic, pancreatitis necrotising, peritoneal necrosis, septic shock. VELCADE dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, AMLODIPINE BESYLATE, FERROUS FUMARATE, PRIMPERAN, INPOMP, CREON, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5635725-3
Physician from JAPAN reported VELCADE problem on Feb 14, 2008. Male patient, 50 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood lactate dehydrogenase increased, disease progression, neoplasm, neutrophil count decreased, platelet count decreased, pleural effusion, pneumonia. VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PLATELETS, RED BLOOD CELLS, MAXIPIME, CARBENIN. Patient was hospitalized. Patient died on 08/19/2007.
Velcade Side Effects Report #5635815-5
VELCADE problem was reported by a Physician from NETHERLANDS on Feb 11, 2008. Male patient, 61 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: optic neuritis, papilloedema. VELCADE dosage: unknown. During the same period patient was treated with NEXIUM. Patient recovered.
Velcade Side Effects Report #5635817-9
Physician from FRANCE reported VELCADE problem on Feb 12, 2008. Male patient, 58 years of age, weighting 138.9 lb, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: ascites, confusional state, diarrhoea, escherichia infection, febrile bone marrow aplasia, gastroenteritis proteus, rectal haemorrhage, septic shock, thrombocytopenia. VELCADE dosage: 2.50 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, ISOPTIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5635818-0
VELCADE problem was reported by a Pharmacist from GERMANY on Feb 11, 2008. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fibrinous bronchitis. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5635819-2
Physician from GERMANY reported VELCADE problem on Feb 11, 2008. Female patient, 68 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: erythema multiforme. VELCADE dosage: 2.17 MG/KG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, FUROSEMIDE, PALLADONE, NEXIUM. Patient recovered.
Velcade Side Effects Report #5639595-9
VELCADE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2008. Male patient, 59 years of age, weighting 209.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: balance disorder, neuralgia, pain, pain in extremity. VELCADE dosage: unknown. During the same period patient was treated with INSULIN, REVLIMID. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5639597-2
Health Professional from UNITED STATES reported VELCADE problem on Feb 12, 2008. Male patient, 64 years of age, weighting 255.5 lb, was diagnosed with lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chills, dialysis, disease progression, fatigue, hyperhidrosis, infection, loss of consciousness, lymphoma, pneumonia. VELCADE dosage: 1.60 MG/M2. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5639599-6
VELCADE problem was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Female patient, 79 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, neutropenia, pancytopenia, rash. VELCADE dosage: 3.08 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, GLYBURIDE, GEMFIBROZIL, AVALIDE, PREVACID, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5641277-4
Physician from ITALY reported VELCADE problem on Feb 15, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, electrocardiogram t wave inversion, syncope. VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with THALOMID, ACETYLSALICYLIC ACID SRT, LANSOPRAZOLE, MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5641378-0
VELCADE problem was reported by a Physician from JAPAN on Feb 20, 2008. Female patient, 51 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma, prophylaxis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin decreased, blood lactate dehydrogenase increased, blood sodium decreased, c-reactive protein increased, disease progression, hepatic function abnormal, hypercalcaemia, laboratory test abnormal. VELCADE dosage: 1.91 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DEXAMETHASONE, MAGNESIUM OXIDE, PROTECADIN, LAMIVUDINE, OXYCONTIN, CEFZON, CALONAL. Patient died on 01/23/2008.
Velcade Side Effects Report #5641581-X
Physician from JAPAN reported VELCADE problem on Feb 14, 2008. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, concomitant disease progression, enterocolitis, lymphocyte count decreased, neutrophil count decreased, oral herpes, pneumonia, protein total decreased. VELCADE dosage: 2.00 MG, INTRAVENOUS; 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.
Velcade Side Effects Report #5641652-8
VELCADE problem was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, antibody test positive, condition aggravated, constipation, diarrhoea, hypertension, interstitial lung disease, neurogenic bladder, neuropathy peripheral. VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.
Velcade Side Effects Report #5641656-5
Physician from JAPAN reported VELCADE problem on Feb 05, 2008. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: dialysis, haemoglobin decreased, hepatic function abnormal, platelet count decreased, pyrexia, renal disorder, tumour lysis syndrome, white blood cell count decreased. VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DIFLUCAN, BAKTAR, MUCOSTA, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE, BONALON, CIPROFLOXACIN. Patient died on 12/12/2007.
Velcade Side Effects Report #5641658-9
VELCADE problem was reported by a Physician from NETHERLANDS on Feb 14, 2008. Male patient, 60 years of age, weighting 160.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: emotional distress, lactic acidosis, tachypnoea. VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5641662-0
Physician from FRANCE reported VELCADE problem on Feb 12, 2008. Male patient, 65 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, bronchitis, clostridium difficile colitis, cytomegalovirus viraemia, interstitial lung disease, legionella serology positive, opportunistic infection. VELCADE dosage: 2.54 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, METHOTREXATE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5641663-2
VELCADE problem was reported by a Physician from FRANCE on Feb 12, 2008. Male patient, 29 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neutropenia, respiratory tract infection. VELCADE dosage: 3.00 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINDESINE, BLEOMYCIN, METHOTREXATE, GRANOCYTE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5641667-X
Physician from JAPAN reported VELCADE problem on Feb 14, 2008. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: constipation, hypokalaemia, hyponatraemia, hypotension, loss of consciousness, platelet count decreased, pyrexia, white blood cell count decreased. VELCADE dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ENTECAVIR HYDRATE, FAMOTIDINE, MAGNESIUM OXIDE, NEUTROGIN, BAKTAR, DIFLUCAN, ZOMETA. Patient recovered.
Velcade Side Effects Report #5641684-X
VELCADE problem was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 65 years of age, weighting 77.16 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, diarrhoea, disease progression, gastritis, hypokalaemia, malaise, nasopharyngitis, orthostatic hypotension. VELCADE dosage: 1.65 MG, INTRAVENOUS; 1.29 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FUNGUARD, MEROPEN, TARGOCID, MINOCYCLINE, IMMUNE GLOBULIN. Patient was hospitalized. Patient died on 08/20/2007.
Velcade Side Effects Report #5641686-3
Physician from JAPAN reported VELCADE problem on Feb 14, 2008. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, constipation, cytomegalovirus infection, nausea, platelet count decreased. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE, BAKTAR, SELBEX, PURSENNID, MAGNESIUM OXIDE, NAUZELIN, CEFAZOLIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5641690-5
VELCADE problem was reported by a Physician from FRANCE on Feb 12, 2008. Male patient, 35 years of age, weighting 156.5 lb, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. VELCADE dosage: 2.79 MG, INTRAVENOUS; 2.84 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642145-4
Physician from JAPAN reported VELCADE problem on Feb 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: constipation, disease progression, hypoaesthesia, nausea, pneumonia aspiration, pyrexia, thrombocytopenia, vomiting. VELCADE dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T, PRIMPERAN. Patient died on 10/23/2007.
Velcade Side Effects Report #5642147-8
VELCADE problem was reported by a Physician from BELGIUM on Feb 11, 2008. Male patient, 76 years of age, weighting 147.7 lb, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac failure, pneumonia. VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642151-X
Physician from PORTUGAL reported VELCADE problem on Feb 13, 2008. Female patient was diagnosed with leukaemia plasmacytic and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hypoxia, pulmonary fibrosis, respiratory failure. VELCADE dosage: 1.30 MG/M2. Patient recovered.
Velcade Side Effects Report #5642153-3
VELCADE problem was reported by a Physician from FRANCE on Feb 14, 2008. Female patient, 66 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia pneumococcal. VELCADE dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642155-7
Physician from GERMANY reported VELCADE problem on Feb 14, 2008. Female patient, weighting 183.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia, suicide attempt. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, TORSEMIDE, POTASSIUM CHLORIDE, ZOLEDRONIC ACID, MESNA, METAMIZOL NATRIUM, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642157-0
VELCADE problem was reported by a Physician from FRANCE on Feb 14, 2008. Male patient, 57 years of age, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral, testicular pain. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5642312-X
Consumer or non-health professional from UNITED STATES reported VELCADE problem on Feb 11, 2008. Male patient, 60 years of age, weighting 140.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia, restrictive pulmonary disease, vertebral injury. VELCADE dosage: unknown. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642314-3
VELCADE problem was reported by a Physician from UNITED STATES on Feb 13, 2008. Male patient, 69 years of age, weighting 204.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: colitis. VELCADE dosage: 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, CISPLATIN, DOXORUBICIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642316-7
Health Professional from UNITED STATES reported VELCADE problem on Feb 14, 2008. Female patient, 63 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, oxygen supplementation, rales, wheezing. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, COMBIVENT, MS CONTIN, PROCARDIA, ATENOLOL, DILANTIN, ZOCOR, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642479-3
VELCADE problem was reported by a Physician from RUSSIAN FEDERATION on Feb 15, 2008. Male patient, 75 years of age, weighting 163.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, nasal congestion. VELCADE dosage: 1.90 MG,. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5642488-4
Physician from FRANCE reported VELCADE problem on Feb 15, 2008. Male patient, 70 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: eyelid oedema. VELCADE dosage: 2.47 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Velcade Side Effects Report #5642503-8
VELCADE problem was reported by a Physician from JAPAN on Feb 15, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, platelet count decreased, pneumonitis, respiratory failure. VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with LASIX, KYTRIL, NEOPHAGEN, SOLITA, FAMOTIDINE, BAKTAR, ALLOPURINOL, DECADRON. Patient died on 01/23/2008.
Velcade Side Effects Report #5643011-0
Pharmacist from UNITED STATES reported VELCADE problem on Feb 27, 2008. Female patient, 80 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chest discomfort, nausea, throat tightness. VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5643880-4
VELCADE problem was reported by a Physician from UNITED STATES on Feb 17, 2008. Female patient, 43 years of age, weighting 174.2 lb, was diagnosed with plasmacytoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diarrhoea, disease progression, electrolyte imbalance, fatigue, heart rate increased, hypermagnesaemia. VELCADE dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with FLAVOPIRIDOL. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5645016-2
Health Professional from UNITED STATES reported VELCADE problem on Feb 15, 2008. Female patient, 68 years of age, weighting 209.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, constipation, syncope. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADVAIR DISKUS, METOPROLOL TARTRATE, PROZAC, PROTONIX, DILTIAZEM, CALCITROL, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5646861-X
VELCADE problem was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, lung disorder, oxygen saturation decreased, platelet count decreased, pleural effusion. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, WARFARIN, AMOBAN, FAMOTIDINE. Patient recovered.
Velcade Side Effects Report #5647903-8
Physician from UNITED STATES reported VELCADE problem on Feb 18, 2008. Male patient, 72 years of age, weighting 189.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aphasia, blood bicarbonate increased, blood ph decreased, blood potassium increased, cerebral hypoperfusion, convulsion, fatigue, fibrosis, hypotension. VELCADE dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, NOVOLIN N, HYZAAR, ATENOLOL, DUONEB, NITROGLYCERIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5648114-2
VELCADE problem was reported by a Physician from JAPAN on Feb 20, 2008. Male patient, 55 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bronchitis, constipation, diarrhoea, epigastric discomfort, headache, herpes virus infection, immune system disorder, neuropathy peripheral. VELCADE dosage: 2.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, LANSOPRAZOLE, SIMVASTATIN, LAXOBERON, AMIKACIN, CARBENIN, KYTRIL. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5648115-4
Physician from CANADA reported VELCADE problem on Feb 19, 2008. Female patient, 76 years of age, weighting 156.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: renal failure. VELCADE dosage: 2.30 MG. During the same period patient was treated with EPREX, PROCHLORPERAZINE. Patient recovered.
Velcade Side Effects Report #5648118-X
VELCADE problem was reported by a Health Professional from COLOMBIA on Feb 19, 2008. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DEXAMETHASONE, PREDNISONE. Patient died on 12/01/2007.
Velcade Side Effects Report #5648120-8
Physician from JAPAN reported VELCADE problem on Feb 19, 2008. Female patient, 61 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, hypotension. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with MUCOSTA, GASMOTIN, DIFLUCAN, ZOVIRAX, CLARITHROMYCIN, OMEPRAL, PYRINAZIN. Patient died on 01/14/2008.
Velcade Side Effects Report #5648201-9
VELCADE problem was reported by a Physician from UNITED STATES on Feb 20, 2008. Male patient, 76 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, aortic valve incompetence, atrial fibrillation, dizziness, haematuria, pulmonary hypertension, tricuspid valve incompetence. VELCADE dosage: 1.30 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, ASPIRIN, LYRICA, FLOMAX, EFFEXOR, LEVAQUIN, HYDRALAZINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5648779-5
Physician from GERMANY reported VELCADE problem on Feb 19, 2008. Male patient, 57 years of age, weighting 179.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: middle ear effusion, pyrexia, rhinitis atrophic. VELCADE dosage: 2.70 MG, INTRAVENOUS. During the same period patient was treated with PANTOPRAZOLE, ACYCLOVIR, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5648789-8
VELCADE problem was reported by a Physician from FRANCE on Feb 21, 2008. Female patient, 60 years of age, weighting 180.8 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: phlebitis, pulmonary embolism, pulmonary infarction. VELCADE dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN SULPHATE, PREDNISONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5648794-1
Physician from JAPAN reported VELCADE problem on Feb 18, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cyst, gallbladder disorder, hepatic cyst, lung disorder, oxygen saturation decreased, platelet count decreased. VELCADE dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ITRACONAZOLE, BAKTAR, FLOMOX, MUCOSTA. Patient recovered.
Velcade Side Effects Report #5583736-9
VELCADE problem was reported by a Physician from JAPAN on Dec 17, 2007. Male patient, 54 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, thrombotic microangiopathy, thrombotic thrombocytopenic purpura. VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5584688-8
Physician from JAPAN reported VELCADE problem on Dec 20, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abnormal behaviour, altered state of consciousness, memory impairment, pain in extremity, restlessness. VELCADE dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5584689-X
VELCADE problem was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: dialysis, tumour lysis syndrome. VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient died on 12/12/2007.
Velcade Side Effects Report #5584696-7
Physician from JAPAN reported VELCADE problem on Dec 21, 2007. Male patient, 57 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, diarrhoea, epistaxis, gastritis haemorrhagic, haematotoxicity, pneumonia bacterial. VELCADE dosage: 2.00 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS; 2.00 MG, INTRAVENOUS, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, PETROLATUM OINTMENT, VIDARABINE, ALPROSTADIL, ZOMETA. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5584697-9
VELCADE problem was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, 72 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: asthma. VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with ORGADRONE, ALENDRONATE, LAMIVUDINE, LANSOPRAZOLE, PURSENNID, BAKTAR, PANTOSIN, WARFARIN POTASSIUM. Patient recovered.
Velcade Side Effects Report #5584698-0
Physician from JAPAN reported VELCADE problem on Dec 20, 2007. Male patient, 47 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome. VELCADE dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BAKTAR, LANSOPRAZOLE, GASMOTIN, PLATELETS, RED BLOOD CELLS. Patient died on 08/14/2007.
Velcade Side Effects Report #5584720-1
VELCADE problem was reported by a Pharmacist from UNITED KINGDOM on Dec 19, 2007. Female patient, 60 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, hyponatraemia, orthostatic hypotension. VELCADE dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with FLUOXETINE, CLODRONATE, OMEPRAZOLE. Patient was hospitalized. Patient died on 07/01/2007.
Velcade Side Effects Report #5584721-3
Physician from JAPAN reported VELCADE problem on Dec 20, 2007. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, constipation, cytomegalovirus infection, nausea, platelet count decreased. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE, BAKTAR, SELBEX, PURSENNID, MAGNESIUM OXIDE, NAUZELIN, CEFAZOLIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5584725-0
VELCADE problem was reported by a Physician from JAPAN on Dec 19, 2007. Female patient, 64 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, anaesthesia, anal erosion, arterial thrombosis limb, aspartate aminotransferase increased, back pain, blood amylase increased, blood calcium decreased, blood lactate dehydrogenase increased. VELCADE dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADONA, TRANSAMIN, DOPAMINE HYDROCHLORIDE, MEROPEN, FAMOTIDINE, CLARITHROMYCIN. Patient died on 12/25/2006.
Velcade Side Effects Report #5584730-4
Physician from JAPAN reported VELCADE problem on Dec 20, 2007. Female patient, 78 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, diarrhoea, malignant neoplasm progression, multiple myeloma, nausea, oedema, platelet count decreased, pulmonary oedema, pyrexia. VELCADE dosage: 1.90 MG, 1.70 MG , 1.30 MG, 1.90 MG INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, HYDROCORTISONE, WARFARIN, ACECOL, ENDOXAN. Patient was hospitalized. Patient died on 05/12/2007.
Velcade Side Effects Report #5584731-6
VELCADE problem was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, constipation, disease progression, enterocolitis, hypoaesthesia, lymphocyte count decreased, malignant neoplasm progression. VELCADE dosage: 2.00 MG, INTRAVENOUS : 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.
Velcade Side Effects Report #5584738-9
Physician from ARGENTINA reported VELCADE problem on Dec 19, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, pyrexia. VELCADE dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with CORTICOSTEROIDS, DEXAMETHASONE, VITAMIN B, ACYCLOVIR. Patient was hospitalized. Patient died on 11/16/2007.
Velcade Side Effects Report #5584739-0
VELCADE problem was reported by a Physician from ITALY on Dec 18, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: diverticulitis, diverticulum, lung disorder, peridiverticulitis, serositis. VELCADE dosage: 2.07 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5584899-1
Physician from UNITED STATES reported VELCADE problem on Dec 19, 2007. Male patient, 62 years of age, weighting 165.3 lb, was diagnosed with squamous cell carcinoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, granulocytes abnormal, hypocalcaemia, orthostatic hypotension, white blood cell disorder. VELCADE dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5585637-9
VELCADE problem was reported by a Physician from AUSTRALIA on Dec 24, 2007. Male patient, 62 years of age, weighting 205.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: haemoglobin increased, platelet count decreased. VELCADE dosage: 2.80 MG, 2.20 MG. During the same period patient was treated with DEXAMETHASONE, METFORMIN, GLYBURIDE. Patient recovered.
Velcade Side Effects Report #5586077-9
Physician from UNITED STATES reported VELCADE problem on Dec 27, 2007. Female patient, 72 years of age, weighting 117.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, neuropathy peripheral, post polio syndrome, rotavirus infection. VELCADE dosage: 1.00 MG/M2. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5587166-5
VELCADE problem was reported by a Physician from GERMANY on Dec 27, 2007. Female patient, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: arterial haemorrhage, bundle branch block right, duodenal ulcer haemorrhage, gastrointestinal fistula, pleural effusion, pneumonia, tachycardia, upper gastrointestinal haemorrhage. VELCADE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, METRONIDAZOLE, FLUCONAZOLE, MESNA, GRANISETRON, CIPROFLOXACIN, DICLOFENAC. Patient was hospitalized. Patient died on 09/21/2007.
Velcade Side Effects Report #5587178-1
Physician from JAPAN reported VELCADE problem on Dec 27, 2007. Male patient, 55 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bronchitis, constipation, epigastric discomfort, headache, immune system disorder. VELCADE dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, LANSOPRAZOLE, SIMVASTATIN, LAXOBERON, AMIKACIN, CARBENIN, KYTRIL. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5587189-6
VELCADE problem was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, lung disorder, multiple myeloma, oxygen saturation decreased, platelet count decreased, pleural effusion, respiratory disorder. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, WARFARIN, AMOBAN, FAMOTIDINE. Patient recovered.
Velcade Side Effects Report #5587235-X
Physician from JAPAN reported VELCADE problem on Dec 25, 2007. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, disease progression, dyspnoea, metabolic acidosis, oedema, tumour lysis syndrome. VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.
Velcade Side Effects Report #5587529-8
VELCADE problem was reported by a Physician from JAPAN on Dec 25, 2007. Female patient, 67 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, altered state of consciousness, delirium, disorientation, disuse syndrome, hyponatraemia, neuropathy peripheral, platelet count decreased, urine sodium increased. VELCADE dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CLARITHROMYCIN, ITRACONAZOLE, OMEPRAL, LEVOFLOXACIN, VALTREX, NIFEDIPINE. Patient recovered.
Velcade Side Effects Report #5587531-6
Physician from JAPAN reported VELCADE problem on Dec 25, 2007. Male patient, 55 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, neuropathy peripheral, supraventricular extrasystoles. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SUCRALFATE, ITRACONAZOLE, OMEPRAL, URSO, LEVOFLOXACIN, ADALAT, BAKTAR. Patient recovered.
Velcade Side Effects Report #5587540-7
VELCADE problem was reported by a Health Professional from FRANCE on Dec 27, 2007. Male patient, 57 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. VELCADE dosage: 1.85 MG, INTRAVENOUS. During the same period patient was treated with PREVISCAN, KETAMINE, DURAGESIC, ACETAMINOPHEN, OXYCODONE, ZOLPIDEM TARTRATE, VITAMIN B, NEURONTIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5587542-0
Physician from JAPAN reported VELCADE problem on Dec 25, 2007. Female patient, 61 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma, parotitis, pyrexia and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: back pain, blood pressure increased, cough, dizziness, gastritis, hypertension, malaise, neutrophil count decreased. VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with ANTIBIOTICS, PREDNISONE, MAXIPIME, SOLDEM. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5587721-2
VELCADE problem was reported by a Health Professional from UNITED STATES on Dec 29, 2007. Female patient, 74 years of age, weighting 144.8 lb, was diagnosed with neoplasm and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, brain oedema, bronchitis, chest pain, dehydration, dyspnoea, hypotension, metastases to central nervous system, muscular weakness. VELCADE dosage: 2.40 MG,. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5588248-4
Physician from JAPAN reported VELCADE problem on Dec 25, 2007. Male patient, 73 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma, prophylaxis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, disease progression, fungus body fluid identified, inappropriate antidiuretic hormone secretion, interstitial lung disease, orthostatic hypotension, pneumonia bacterial, respiratory failure, respiratory tract infection fungal. VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MEIACT, BAKTAR, ITRACONAZOLE, DECADRON, RABEPRAZOLE, AMLODIPINE BESYLATE, BASEN. Patient recovered.
Velcade Side Effects Report #5588249-6
VELCADE problem was reported by a Physician from JAPAN on Dec 28, 2007. Male patient, 73 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood lactate dehydrogenase increased, lung disorder, platelet count decreased. VELCADE dosage: 2.3 MG, INTRAVENOUS; 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5588251-4
Physician from JAPAN reported VELCADE problem on Dec 25, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy. VELCADE dosage: 1.70 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.
Velcade Side Effects Report #5589383-7
VELCADE problem was reported by a Physician from THAILAND on Jan 03, 2008. Female patient, 59 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient